You are here PRODUCTS >> CELL LINES >> iPSc & iPSc DERIVATIVES >> CELTHER INCUDED CARDIOMYOCYTES
PRODUCTS
INDUCED CARDIOMYOCYTES - UNDER DEVELOPMENT
Induced Cardiomyocytes are human cardiomyocytes derived from iPS cells through Celther proprietary differentiation protocols.
Immunofluorescence studies indicate expression of the alpha-myosin heavy chain (Myh6). Induced Cardiomyocytes culture consist of beating areas containing contracting cardiomyocytes.
These human cardiac cells are specifically designed to aid drug discovery and improve the predictability of drug efficacy and toxicity screens, weeding out ineffective and potentially toxic compounds early in the pharmaceutical pipeline process before significant time and resources have been invested. Look at more information here: CELTHER CARDIOMYOCYTES BROCHURE
Immunofluorescence studies indicate expression of the alpha-myosin heavy chain (Myh6). Induced Cardiomyocytes culture consist of beating areas containing contracting cardiomyocytes.
These human cardiac cells are specifically designed to aid drug discovery and improve the predictability of drug efficacy and toxicity screens, weeding out ineffective and potentially toxic compounds early in the pharmaceutical pipeline process before significant time and resources have been invested. Look at more information here: CELTHER CARDIOMYOCYTES BROCHURE
Celther Induced Cardiomyocytes
Cell Type:
CLTH/induced cardiomyocytes
Celther Catalog number:
CL 05003-CLTH
Organism:
Human
Source:
Differentiated from human iPS cell line
Quantity:
>1 X 106 cells / vial
Shipped:
Frozen
Storage:
Liquid nitrogen
Growth Properties:
Adherent
Media:
Celther Induced Cardiomyocytes Medium
Regulatory Statement:
For Research Use Only.
Not for use in diagnostic procedures.
Not for use in diagnostic procedures.